Background: Thepersistenceoffemalegenitalmutilation(FGM)insomecountries,de-
| INTRODUCTION

Femalegenitalmutilation(FGM)remainsasignificantpublichealth
issue and a leading cause of several health complications among girls and women who have undergone the practice. [1] [2] [3] It is also recognized as a violation of the human rights of girls and women, including the right to freedom from torture or cruel, inhuman, or degrading treatment or punishment, the right to the highest ©2017InternationalFederationofGynecologyandObstetrics. TheWorldHealthOrganizationretainscopyrightandallotherrightsinthemanuscriptofthisarticleassubmittedforpublication.
attainable standard of health, and the right to life when it results in death. 4, 5 According to a recent UNICEF report, at least 200 million girls and women have been subjected to FGM worldwide. More than half of these cases took place in three countries: Indonesia, Egypt, and Ethiopia. 6 However, there is a decline in the prevalence in some countries. Over the past three decades, the number of girls aged
15-19yearswhohaveundergoneFGMhasdecreasedfromoneintwo
girls in the mid-1980s to about one in three girls today. 7 Immigration andglobalpopulationmovementshasalsoledtoFGMbeingreported in Europe, the USA, New Zealand, Canada, and Australia. 7 StudieshaveshownthatwomenwhohaveundergoneFGMhave asignificantlyhigherriskofhealthcomplicationsduringchildbirthand sexualhealthproblemscomparedwithwomenwithoutFGM.
2,3
FGM may also cause gynecological and mental health problems, all of which can have a huge impact on the social esteem of individuals. 8, 9 In the past years, there has been a progressive trend toward the 
medicalizationofFGM(includingreinfibulationofwomenwithtypeIII FGMwhohavebeendeinfibulatedduringchildbirth
21-23
These studies point to the need to support healthcare providers who treat girls and women who have undergone the procedure, includingensuringtheyhavecurrent,appropriateinformationonFGM.
Thisreviewsoughttodeterminetheimpactofprovidinginformation on FGM and its consequences to healthcare providers on their attitudestowardFGM,andqualityofcareandpatientsatisfaction.
| MATERIALS AND METHODS
The present systematic review was conducted in agreement with thePRISMA(PreferredReportingItemsforSystematicReviewsand Meta-Analyses)guidelinesforreportingsystematicreviewsandmetaanalyses of randomized controlled trials. 24 
| Literature search
We performed a systematic search of the following electronic da- 
| Study selection
Two team members independently screened titles, abstracts, and the full text of relevant articles. A third team member resolved disagreements. Inclusion and exclusion criteria were defined a priori.
Studies had to include healthcare providers providing care for girls andwomenlivingwithanytypeofFGM.Randomizedcontrolledstudies,nonrandomizedcomparativeclinicaltrials,cohort(prospectiveor retrospective),case-control(includingstudieswithhistoricalcontrol group),controlledbeforeandafterstudies,interruptedtimeseriesand cross-sectional studies with comparative analysis of subsets of exposed (cases) and unexposed (controls) were considered for inclusion.
We considered any intervention aimed at improving information on Other outcomes were healthcare providers' attitudes toward FGM, rateofFGMdocumentation,correctdiagnosisandcorrecttreatment, and any reported adverse events.
TheprotocolforthisreviewwasregisteredwiththeInternational
ProspectiveRegisterofSystematicReviews(PROSPERO)withregistrationnumberCRD42015024570.
| Data collection
Two team members independently collected data on study design, patients'characteristics,interventions,follow-up,andoutcomesusinga dataextractionform.Discrepancieswereresolvedthroughdiscussion withotherauthors.Theriskofbiaswasassessedforeachoutcome usingaCochraneRiskofBiasAssessmentToolforNon-Randomized studiesofIntervention(ACROBAT-NRSI). 
| Data analysis
The statistical analyses were performed according to the guidelines set by the Cochrane Collaboration. 26 All outcomes were analyzed using intent-to-treat. Data were analyzed using RevMan 5. 
| RESULTS
Intotal,thesearchyielded3782nonduplicaterecords;2784titlesand abstracts were screened for eligibility followed by assessment of the fulltextof21potentiallyeligiblestudies (Fig.1) . Theriskofbiasduetoconfounding,selectionofparticipants,selection of the reported results, and missing data were judged to be "moderate,"whiletheriskofbiasinthemeasurementofintervention, departures from intended interventions, and measurement of outcomes were judged to be "low." The study did not report comparison betweentheinterventionandcontrolgroupsregardingsomeoftheir statedobjectives.Theoveralljudgmentoftheriskofbiaswasfound to be "moderate."
| Outcomes measured among healthcare providers
| Knowledge of immediate and long-term complications from FGM
There was no statistically significant difference in the number of healthcare providers in the experimental sites who could cite at leastthreepossiblehealthcomplicationsfromFGMpostintervention,comparedwiththecontrolsite(RR0.97;95%CI,0.77-1.22; Fig.2 ).
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| Providers' attitudes toward FGM
The percentage of healthcare providers in the experimental group The quality of evidence of these outcomes was very low owing to smallsamplesize,selectionbias,impreciseresults,andindirectcomparison.Theinterventionandcontrolgroupsdonotappeartobecomparable at baseline. In conclusion, the study included in this review showed that 
| DISCUSSION
